ATYR: the balance sheet

MyFinsight

For the year ending 2025-12-31, ATYR has $93,003K in assets. $10,743K in cash and cash equivalents.

Balance Sheets	2025-12-31
Cash and cash equivalents	10,743
Available-for-sale investments	67,944
Other receivables	873
Prepaid expenses	677
Total current assets	80,237
Restricted cash	2,235
Property and equipment, gross	9,091
Less accumulated depreciation and amortization	4,828
Property and equipment, net	4,263
Operating lease, right-of-use assets	5,524
Financing lease, right-of-use assets	596
Other assets	148
Total assets	93,003

Accounts payable	3,891
Accrued expenses	9,791
Current portion of operating lease liability	836
Current portion of financing lease liability	630
Total current liabilities	15,148
Long-term operating lease liability, net of current portion	10,308
Long-term financing lease liability, net of current portion	259
Common stock, 0.001 par value per share 170,000,000 authorized shares as of december 31, 2025 and 2024, respectively issued and outstanding shares - 98,031,104 as of december 31, 2025 and 84,038,922 as of december 31, 2024, respectively	98
Additional paid-in capital	673,554
Accumulated other comprehensive loss	-8
Accumulated deficit	-606,164
Total atyr pharma stockholders equity	67,480
Noncontrolling interest in pangu biopharma limited	-192
Total stockholders' equity	67,288
Total liabilities and stockholders equity	93,003

Unit: Thousand (K) dollars (except for numbers of shares and EPS).